GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HCmed Innovations Co Ltd (ROCO:6934) » Definitions » Cash Flow from Others

HCmed Innovations Co (ROCO:6934) Cash Flow from Others : NT$-11.9 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is HCmed Innovations Co Cash Flow from Others?

HCmed Innovations Co's cash flow from others for the six months ended in Dec. 2024 was NT$-11.8 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-11.9 Mil.


HCmed Innovations Co Cash Flow from Others Historical Data

The historical data trend for HCmed Innovations Co's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HCmed Innovations Co Cash Flow from Others Chart

HCmed Innovations Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Cash Flow from Others
1.57 -1.44 23.32 -11.88

HCmed Innovations Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow from Others Get a 7-Day Free Trial - - 23.32 -0.08 -11.80

HCmed Innovations Co Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-11.9 Mil.

HCmed Innovations Co Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of HCmed Innovations Co's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


HCmed Innovations Co Business Description

Traded in Other Exchanges
N/A
Address
Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033
HCmed Innovations Co Ltd is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product include Pulmogine and AdheResp.

HCmed Innovations Co Headlines

No Headlines